Arbutus Biopharma Corp (ABUS) stock buyback history
4 share repurchase announcements by Arbutus Biopharma Corp on file, newest first. ABUS stock overview.
| Date | Announcement | Type | Amount as stated | Source |
|---|---|---|---|---|
| 7:30 AM ET | Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer | Tender offer | Tender offer for up to US$230 Million | |
| 7:30 AM ET | Arbutus Commences US$230 Million Modified “Dutch Auction” Tender Offer of its Common Shares at a Price Not Greater Than US$5.75 Nor Less Than US$5.00 Per Share | Tender offer | Tender offer for up to US$230 Million | |
| 7:30 AM ET | Arbutus Announces Intent to Repurchase Up to US$230 Million of its Common Shares Through Modified “Dutch Auction” Tender Offer | Tender offer | Tender offer for up to US$230 Million | |
| 7:31 AM ET | Arbutus Biopharma Corp filed Form 8-K about share repurchases | Other buyback news | Not stated |
Other companies: latest stock buyback announcements.
About this data
An authorization lets a company buy back shares up to a stated amount over time. It does not mean any shares have been bought, and a company can buy fewer shares or none.
Amounts are copied from the release headline where it states one. Where only an SEC filing is on file, the amount comes from Signal8’s summary of that filing and is marked as such. Rows with no stated amount say so.
A press release and the SEC filing that carries it are shown as one announcement, with both linked. Each row is dated by when the company published it, in US Eastern time. Routine progress notices (daily or weekly purchase reports) are not listed.
Facts from company press releases and SEC filings. Not investment advice.